Family Medicine | Page 345 of 374 | Links Medicus Content Curation & Alerts in Medicine

“Adults hospitalized with CAP who had radiologic evidence of pneumonia on CT but not concurrent CXR had similar pathogens, disease severity, and outcomes compared with patients who had signs of pneumonia on CXR”.

Guideline: Osteoarthritis of the Knee Clical Care Standard

29 Aug, 2017 | 15:00h | UTC

Osteoarthritis of the Knee Clical Care Standard – Australian Commission on Safety and Quality in Health Care (PDF Guideline and other resources)

Source: Research Review Australia (free resource to find articles of interest)

Review: DRESS: What does the emergency physician need to know?

29 Aug, 2017 | 14:54h | UTC

DRESS: What does the emergency physician need to know? – emDocs (free)

#ESCCongress – Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

27 Aug, 2017 | 20:07h | UTC

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation – New England Journal of Medicine (free)

Commentaries: Randomized Evaluation of Dual Antithrombotic Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With Nonvalvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention – RE-DUAL PCI – American College of Cardiology, Latest in Cardiology (free) Dual Antithrombotic Therapy Is Safe for Patients with AF and a New Stent – Physician’s First Watch (free) AND When two is better than three: Dual antithrombotic therapy cuts bleeding risk – Brigham and Women’s Hospital, via ScienceDaily (free)

“In summary, several lines of evidence now suggest that it is safe to treat atrial fibrillation patients who undergo coronary revascularization with anticoagulation (warfarin studied in WOEST, rivaroxaban studied in PIONEER AF-PCI, dabigatran studied in RE-DUAL PCI) and clopidogrel monotherapy” (from American College of Cardiology, Latest in Cardiology).

#ESCCongress – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases

27 Aug, 2017 | 20:10h | UTC

2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries (free) (RT @rafavidalperez see Tweet)

See also: #ESCCongress Slides (free PPT file)

#ESCCongress – 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease

27 Aug, 2017 | 20:09h | UTC

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS (free) (RT @rafavidalperez see Tweet)

See also: #ESCCongress Slides (free PPT file)

#ESCCongress – Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease

27 Aug, 2017 | 20:08h | UTC

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease – New England Journal of Medicine (free)

Editorial by Dr. Eugene Braunwald: An Important Step for Thrombocardiology (free)

Commentaries: Cardiovascular Outcomes for People Using Anticoagulation Strategies – COMPASS – American College of Cardiology, Latest in Cardiology (free) AND COMPASS: Does Rivaroxaban Plus Aspirin Improve CV Outcomes in Patients With Stable Atherosclerotic Vascular Disease or PAD? – ACC News Story (free) AND Rivaroxaban, Aspirin, or Both in Stable Coronary Disease – Physician’s First Watch (free)

The primary outcome (composite of cardiovascular death, stroke, or myocardial infarction) occurred in fewer patients in the rivaroxaban-plus-aspirin group than in the aspirin-alone group (4.1% vs. 5.4% / Absolute risk difference = 1.3% / NNT = 76), but major bleeding events occurred in more patients in the rivaroxaban-plus-aspirin group (3.1% vs. 1.9% / Absolute risk difference = 1.2 / NNH = 83).

Review: Malignant Otitis Externa: Diagnosis and Treatment

26 Aug, 2017 | 20:30h | UTC

Malignant Otitis Externa: Diagnosis and Treatment – emDocs (free)

#ESCCongress – Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population

27 Aug, 2017 | 20:03h | UTC

Incidence of Previously Undiagnosed Atrial Fibrillation Using Insertable Cardiac Monitors in a High-Risk Population: The REVEAL AF Study (free)

Commentaries: What Do Implanted Cardiac Monitors Reveal About Atrial Fibrillation? – JAMA Cardiology (free) AND REVEAL AF: Incidence of AFib Could Be Substantial in Older Patients With Stroke Risk Factors – American College of Cardiology, Latest in Cardiology (free) AND Detection of Undiagnosed AF Using Insertable Cardiac Monitors – American College of Cardiology, Latest in Cardiology (free)

Implanted Cardiac Monitors showed the incidence of intermittent atrial fibrillation is extremely common among older individuals with stroke risk factors, but the clinical significance of these findings (do they need to be anticoagulated??) remains to be determined by further trials.

“Previous long-term monitoring studies have suggested that patients with short episodes of subclinical AF have a lower risk of stroke compared with traditional clinical AF, which raises important questions about the risk-benefit ratio of anticoagulation in this setting” (from Latest in Cardiology).

Study: Is Parkinson’s Care Via Telemedicine as Effective as Going to the Clinic?

26 Aug, 2017 | 20:24h | UTC

National randomized controlled trial of virtual house calls for Parkinson disease – Neurology (link to abstract – $ for full-text)

Press release: Is Parkinson’s Care Via Telemedicine as Effective as Going to the Clinic? – American Academy of Neurology (free)

Commentaries: How Telemedicine Helps Those With Parkinson’s – Huffington Post (free) AND Telemedicine Equals Office Visits in Parkinson’s – MedPage Today (free registration required)

#ESCCongress – CI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease

27 Aug, 2017 | 20:02h | UTC

CI Versus CABG in Patients With Type 1 Diabetes and Multivessel Disease – Journal of The American College of Cardiology (link to abstract – $ for full-text)

Commentaries: Patients With Type 1 Diabetes and Multivessel Disease Have Greater Benefit From CABG Than PCI – American College of Cardiology, Latest in Cardiology (free) AND Revascularization in Patients With Type 1 Diabetes – American College of Cardiology, Latest in Cardiology (free)

CABG Appears Superior to PCI for Patients With Type 1 Diabetes, Multivessel Disease – TCTMD (free)

“The observational findings support existing recommendations favoring surgical revascularization in patients with diabetes” (from TCTMD).

Stay Updated in Your Specialty